Clinical guideline recommendations for antipsychotic long-acting injections.

@article{Kane2009ClinicalGR,
  title={Clinical guideline recommendations for antipsychotic long-acting injections.},
  author={John M. Kane and Carlos Garc{\'i}a-Ribera},
  journal={The British journal of psychiatry. Supplement},
  year={2009},
  volume={52},
  pages={S63-7}
}
BACKGROUND Long-acting injections (LAIs) of antipsychotic drugs were developed over 40 years ago in an attempt to improve the long-term treatment of schizophrenia. AIMS To review existing guidelines concerning antipsychotic use generally, and LAIs in particular, and how patients might be identified as potential candidates for LAI treatment. METHOD Literature review. RESULTS Currently several first-generation and one second-generation antipsychotic LAIs are available, with others under… CONTINUE READING

From This Paper

Figures, tables, and topics from this paper.

Citations

Publications citing this paper.
Showing 1-10 of 62 extracted citations

Olanzapine Long-Acting Injection

Drugs • 2010
View 8 Excerpts
Highly Influenced

References

Publications referenced by this paper.
Showing 1-10 of 22 references

Similar Papers

Loading similar papers…